Evidence map›Paper›PMID 10934229›Full record

ArticleThe Journal of experimental medicine2000

Cell-specific transcriptional regulation of human leukotriene B(4) receptor gene.

K Kato, T Yokomizo, T Izumi, T Shimizu

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of experimental medicine, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it, 93 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. [Prognostic implications and functional enrichment analysis of LTB4R in patients with acute myeloid leukemia].Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2022
    Article
  6. Article
  7. Expression of leukotriene BCellular & molecular immunology · 2021
    Article
  8. Leukotriene receptors as potential therapeutic targets.The Journal of clinical investigation · 2018
    Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Leukotriene B4 release from mast cells in IgE-mediated airway hyperresponsiveness and inflammation.American journal of respiratory cell and molecular biology · 2009
    Article
  16. Differential induction of BLT receptor expression on human endothelial cells by lipopolysaccharide, cytokines, and leukotriene B4.Proceedings of the National Academy of Sciences of the United States of America · 2006
    Article
  17. Article
  18. Article
  19. Requirement for leukotriene B4 receptor 1 in allergen-induced airway hyperresponsiveness.American journal of respiratory and critical care medicine · 2005
    Article
  20. 5-Lipoxygenase Pathway, Dendritic Cells, and Adaptive Immunity.Journal of biomedicine & biotechnology · 2004
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

K KatoDepartment of Biochemistry and Molecular Biology, Faculty of Medicine, The University of Tokyo, Tokyo 113-0033, Japan.
T Yokomizo
T Izumi
T Shimizu
The University of Tokyo · JPJapan Science and Technology Agency · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Leukotriene B(4) (LTB(4)) is a lipid mediator that activates leukocytes and is involved in host defense and inflammation. BLT1, a high-affinity receptor for LTB(4) (originally termed BLT), is expressed exclusively in inflammatory cells and is inducible in macrophages upon activation. The mechanisms of tissue-specific expression and induction of BLT1 are important for the understanding of mechanism of onset and the potential treatment of inflammatory disorders. Here, we report the genomic structure and a promoter analysis of the human BLT1 gene, with an emphasis on the mechanism of cell-specific transcription. No TATA or CAAT elements exist around the transcription initiation sites, but a GC-rich sequence is observed in this region. A reporter gene assay revealed that a region approximately 80 basepair upstream from the initiator sequence is required for the basal transcription of the BLT1 gene. Sp1 was found to be a major activator of basal transcription by electrophoretic mobility shift assays and site-directed mutagenesis. The CpG sites of the BLT1 promoter region were highly methylated in BLT1-nonexpressing cells, but not methylated in BLT1-expressing cells. Further, methylation of this region in vitro inhibited the promoter activity to approximately 15% of the control. Thus, methylation at CpG sites in the promoter region is important for cell-specific transcription of the BLT1 gene. The promoter region of the BLT1 gene is localized within the open reading frame (ORF) of the BLT2 gene, which encodes a low-affinity receptor for LTB(4) (Yokomizo, T., K. Kato, K. Terawaki, T. Izumi, and T. Shimizu. 2000. J. Exp. Med. 192:421-431). To our knowledge, this is the first example of "promoter in ORF" in higher eukaryotes.

Indexed as

Gene Expression Regulation5' Untranslated RegionsBase SequenceCpG IslandsDNA, ComplementaryDNA MethylationElectrophoresis, Polyacrylamide GelHeLa CellsHL-60 CellsHumansMolecular Sequence DataMutagenesis, Site-DirectedOpen Reading FramesPromoter Regions, GeneticReceptors, Leukotriene B4Transcription, Genetic5' Untranslated RegionsDNA, ComplementaryReceptors, Leukotriene B4

Identifiers

PMID10934229
PMCPMC2193224
OpenAlexW2160385094

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.